BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

716 related articles for article (PubMed ID: 16794079)

  • 1. A topoisomerase IIbeta-mediated dsDNA break required for regulated transcription.
    Ju BG; Lunyak VV; Perissi V; Garcia-Bassets I; Rose DW; Glass CK; Rosenfeld MG
    Science; 2006 Jun; 312(5781):1798-802. PubMed ID: 16794079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcription. Gene expression needs a break to unwind before carrying on.
    Haince JF; Rouleau M; Poirier GG
    Science; 2006 Jun; 312(5781):1752-3. PubMed ID: 16794066
    [No Abstract]   [Full Text] [Related]  

  • 3. A breaking strategy for topoisomerase IIbeta/PARP-1-dependent regulated transcription.
    Ju BG; Rosenfeld MG
    Cell Cycle; 2006 Nov; 5(22):2557-60. PubMed ID: 17106262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promoter cleavage: a topoIIbeta and PARP-1 collaboration.
    Lis JT; Kraus WL
    Cell; 2006 Jun; 125(7):1225-7. PubMed ID: 16814707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poly(ADP-ribose) polymerases PARP1 and PARP2 modulate topoisomerase II beta (TOP2B) function during chromatin condensation in mouse spermiogenesis.
    Meyer-Ficca ML; Lonchar JD; Ihara M; Meistrich ML; Austin CA; Meyer RG
    Biol Reprod; 2011 May; 84(5):900-9. PubMed ID: 21228215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucocorticoid Receptor Transcriptional Activation via the BRG1-Dependent Recruitment of TOP2β and Ku70/86.
    Trotter KW; King HA; Archer TK
    Mol Cell Biol; 2015 Aug; 35(16):2799-817. PubMed ID: 26055322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poly(ADP-ribose)polymerase-1 (PARP1) controls adipogenic gene expression and adipocyte function.
    Erener S; Hesse M; Kostadinova R; Hottiger MO
    Mol Endocrinol; 2012 Jan; 26(1):79-86. PubMed ID: 22053002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topoisomerase IIβ associates with Ku70 and PARP-1 during double strand break repair of DNA in neurons.
    Mandraju R; Chekuri A; Bhaskar C; Duning K; Kremerskothen J; Kondapi AK
    Arch Biochem Biophys; 2011 Dec; 516(2):128-37. PubMed ID: 22019940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A critical role for topoisomerase IIb and DNA double strand breaks in transcription.
    Calderwood SK
    Transcription; 2016 May; 7(3):75-83. PubMed ID: 27100743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential cytotoxic pathways of topoisomerase I and II anticancer agents after overexpression of the E2F-1/DP-1 transcription factor complex.
    Hofland K; Petersen BO; Falck J; Helin K; Jensen PB; Sehested M
    Clin Cancer Res; 2000 Apr; 6(4):1488-97. PubMed ID: 10778981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA breaks and chromatin structural changes enhance the transcription of autoimmune regulator target genes.
    Guha M; Saare M; Maslovskaja J; Kisand K; Liiv I; Haljasorg U; Tasa T; Metspalu A; Milani L; Peterson P
    J Biol Chem; 2017 Apr; 292(16):6542-6554. PubMed ID: 28242760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation between carcinogenesis, chromatin structure and poly(ADP-ribosylation) (review).
    Boulikas T
    Anticancer Res; 1991; 11(2):489-527. PubMed ID: 1905900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. hPMC2 is required for recruiting an ERbeta coactivator complex to mediate transcriptional upregulation of NQO1 and protection against oxidative DNA damage by tamoxifen.
    Sripathy SP; Chaplin LJ; Gaikwad NW; Rogan EG; Montano MM
    Oncogene; 2008 Oct; 27(49):6376-84. PubMed ID: 18663360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA oxidation as triggered by H3K9me2 demethylation drives estrogen-induced gene expression.
    Perillo B; Ombra MN; Bertoni A; Cuozzo C; Sacchetti S; Sasso A; Chiariotti L; Malorni A; Abbondanza C; Avvedimento EV
    Science; 2008 Jan; 319(5860):202-6. PubMed ID: 18187655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment with the PARP-inhibitor PJ34 causes enhanced doxorubicin-mediated cell death in HeLa cells.
    Magan N; Isaacs RJ; Stowell KM
    Anticancer Drugs; 2012 Jul; 23(6):627-37. PubMed ID: 22293659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reciprocal binding of PARP-1 and histone H1 at promoters specifies transcriptional outcomes.
    Krishnakumar R; Gamble MJ; Frizzell KM; Berrocal JG; Kininis M; Kraus WL
    Science; 2008 Feb; 319(5864):819-21. PubMed ID: 18258916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poly(ADP-ribose) polymerase-1 activation during DNA damage and repair.
    Dantzer F; Amé JC; Schreiber V; Nakamura J; Ménissier-de Murcia J; de Murcia G
    Methods Enzymol; 2006; 409():493-510. PubMed ID: 16793420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of nucleotide sequence-dependent DNA binding of poly(ADP-ribose) polymerase in a purified system.
    Huang K; Tidyman WE; Le KU; Kirsten E; Kun E; Ordahl CP
    Biochemistry; 2004 Jan; 43(1):217-23. PubMed ID: 14705948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ARTD1-induced poly-ADP-ribose formation enhances PPARγ ligand binding and co-factor exchange.
    Lehmann M; Pirinen E; Mirsaidi A; Kunze FA; Richards PJ; Auwerx J; Hottiger MO
    Nucleic Acids Res; 2015 Jan; 43(1):129-42. PubMed ID: 25452336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The DNA topoisomerase IIbeta binding protein 1 (TopBP1) interacts with poly (ADP-ribose) polymerase (PARP-1).
    Wollmann Y; Schmidt U; Wieland GD; Zipfel PF; Saluz HP; Hänel F
    J Cell Biochem; 2007 Sep; 102(1):171-82. PubMed ID: 17340632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.